Showing results (871-880 of 1,068) with videos related to
Sort By:
Pageof 107
Journal of Pharmacokinetics and Pharmacodynamics|September 28, 2006
Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteriaSmita A Kshirsagar, Terrence F Blaschke, Lewis B Sheiner, et al.Journal of Pharmacokinetics and Pharmacodynamics|May 11, 2010
Fractional dynamics pharmacokinetics-pharmacodynamic modelsDavide VerottaJournal of Pharmacokinetics and Pharmacodynamics|May 13, 2009
Numerical validation and properties of a rapid binding approximation of a target-mediated drug disposition pharmacokinetic modelAnshu Marathe, Wojciech Krzyzanski, Donald E MagerJournal of Pharmacokinetics and Pharmacodynamics|December 25, 2008
An interface model for dosage adjustment connects hematotoxicity to pharmacokineticsC Meille, A Iliadis, D Barbolosi, et al.Journal of Pharmacokinetics and Pharmacodynamics|June 23, 2009
When is a metric not a metric? Remarks on direct curve comparison in bioequivalence studiesWojciech JawieńJournal of Pharmacokinetics and Pharmacodynamics|January 9, 2009
Drug-drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial resultsMarylore Chenel, François Bouzom, Fanny Cazade, et al.Journal of Pharmacokinetics and Pharmacodynamics|January 10, 2009
Combining MCMC with 'sequential' PKPD modellingDavid Lunn, Nicky Best, David Spiegelhalter, et al.Journal of Pharmacokinetics and Pharmacodynamics|July 7, 2009
Target-mediated drug disposition model: relationships with indirect response models and application to population PK-PD analysisLeonid Gibiansky, Ekaterina GibianskyJournal of Pharmacokinetics and Pharmacodynamics|August 15, 2009
Performance in population models for count data, part II: a new SAEM algorithmRadojka Savic, Marc LavielleJournal of Pharmacokinetics and Pharmacodynamics|September 17, 2009
Analysis of PK/PD risk factors for development of type 2 diabetes in high risk population using Bayesian analysis of glucose-insulin kineticsChih-Wei Lin, Peter Veng-PedersenPageof 107